SGCE Gene DYT11 NGS Genetic DNA Test
Comprehensive Genetic Testing for Dystonia Disorders
The SGCE Gene DYT11 NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, specifically designed to identify mutations in the sarcoglycan epsilon (SGCE) gene associated with DYT11 dystonia. This advanced genetic analysis provides critical insights for patients experiencing movement disorders and helps neurologists develop targeted treatment strategies.
What Does the SGCE Gene DYT11 Test Measure?
This sophisticated genetic test utilizes next-generation sequencing (NGS) technology to comprehensively analyze the SGCE gene for pathogenic variants. The test specifically detects:
- Point mutations in the SGCE gene coding regions
- Small insertions and deletions affecting gene function
- Genetic variations linked to autosomal dominant myoclonus-dystonia syndrome
- Mutations affecting epsilon-sarcoglycan protein production
Who Should Consider SGCE Gene DYT11 Testing?
This genetic test is recommended for individuals presenting with symptoms suggestive of myoclonus-dystonia syndrome, including:
- Involuntary muscle contractions (dystonia) affecting specific body regions
- Rapid, brief muscle jerks (myoclonus) typically in upper body
- Onset of symptoms in childhood or early adolescence
- Family history of movement disorders or dystonia
- Alcohol-responsive movement symptoms
- Writer’s cramp or other task-specific dystonias
Clinical Benefits of SGCE Genetic Testing
Undergoing SGCE Gene DYT11 testing provides numerous clinical advantages:
- Accurate Diagnosis: Confirms or rules out genetic causes of movement disorders
- Treatment Guidance: Informs medication selection and therapeutic approaches
- Family Planning: Provides genetic counseling information for family members
- Prognostic Information: Helps predict disease progression and symptom management
- Research Contribution: Advances understanding of neurological genetic disorders
Understanding Your Test Results
Your SGCE Gene DYT11 test results will be carefully interpreted by our genetic specialists:
- Positive Result: Indicates presence of pathogenic SGCE mutation, confirming DYT11 diagnosis
- Negative Result: Suggests symptoms may have other genetic or non-genetic causes
- Variant of Uncertain Significance: Requires additional family studies for interpretation
- Carrier Status: Important for family members considering genetic testing
All results include comprehensive genetic counseling to ensure complete understanding and appropriate next steps.
Test Pricing and Details
| Test Component | Details |
|---|---|
| Test Name | SGCE Gene DYT11 NGS Genetic DNA Test |
| Discount Price | $500 USD |
| Regular Price | $700 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
| Testing Method | Next-Generation Sequencing (NGS) |
Pre-Test Requirements
Before scheduling your SGCE Gene DYT11 test, please ensure:
- Complete clinical history documentation
- Genetic counseling session to create family pedigree chart
- Discussion of testing implications with healthcare provider
- Understanding of potential results and their meanings
Nationwide Testing Availability
General Genetics Corporation offers SGCE Gene DYT11 testing across the United States with convenient locations in:
- New York, NY
- Los Angeles, CA
- Chicago, IL
- Houston, TX
- Phoenix, AZ
- Philadelphia, PA
- San Antonio, TX
- San Diego, CA
- Dallas, TX
- San Jose, CA
And many other major metropolitan areas throughout the country.
Take Control of Your Neurological Health
Don’t let unexplained movement symptoms control your life. The SGCE Gene DYT11 NGS Genetic DNA Test provides the clarity needed for proper diagnosis and treatment planning. Our team of genetic specialists and neurologists work together to ensure you receive comprehensive care and support throughout the testing process.
Ready to schedule your test? Call us today at +1(267) 388-9828 or book your appointment online. Take the first step toward understanding your neurological health with advanced genetic testing from General Genetics Corporation.
